Demographic, Clinical and Anatomical and Pathological Variables in Deaths of the Nephrology Department of Dr. Luis Díaz Soto Hospital (1974-2013)

Juan Castañer Moreno; José Hurtado de Mendoza Amat; Lázaro Capote Pereira; Teresita Montero González; Ivan Teuma Cortés; Jorge Fuentes Abreu; René Rodríguez Batista; Jorge Luis Barroso Cruz

2016, Number 1

<< Back Next >>

Rev Cub Med Mil 2016; 45 (1)

Demographic, Clinical and Anatomical and Pathological Variables in Deaths of the Nephrology Department of 'Dr. Luis Díaz Soto' Hospital (1974-2013)

Castañer MJ, Hurtado MAJ, Capote PL, Montero GT, Teuma CI, Fuentes AJ, Rodríguez BR, Barroso CJL

Full text

How to cite this article

Language: Spanish
References: 29
Page:
PDF size: 343.89 Kb.

ABSTRACT

Introduction: Renal diseases are a frequent cause of medical consultation, hospitalization and mortality.
Objective: Analyze some demographic, clinical and anatomical and pathological variables in the deaths of renal diseases during 40 years in a Nephrology service.
Methods: A retrospective and observational study was conducted of demographic, clinical and anatomical and pathological variables in 272 deaths of the nephrology service at "Dr. Luis Díaz Soto" hospital, who were autopsied, from 1974 to 2013.
Results: There were predominantly male patients, white skin and aged 35 to 64 years. The average age has been increasing. The main clinical diagnoses of direct cause of death were bronchopneumonia, acute myocardial infarction and shock. As a basic cause, chronic renal failure, arterial hypertension and diabetes mellitus were considered. In anatomical and pathological studies, bronchopneumonia, pulmonary edema, shock and acute myocardial infarction were identified as more frequent causes of death; while in the main diagnoses of the basic cause of death, the terminal kidney, hypertensive heart disease, diabetes mellitus, and atherosclerosis were documented.
Conclusions: Mortality, necropsy, and clinical pathological correspondence indicators were adequate. There was a progressive increase in the age of the deceased patients studied. Bronchopneumonia and heart disease were the main causes of death. Signs of atherosclerosis were present in most of the studies.

REFERENCES

Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives -a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247-59.
Meguid El Nahas A, Bello AK. Chronic kidney disease: The global challenge. The Lancet. 2005;365(9456):331-40.
Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med. 2004;141(2):95-101.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk a systematic review. J Am SocNephrol. 2006;17(7):2034- 47.
Morrish NJ, Wang SL, Stevens LK, Fuller JH. Mortality and causes of death in the WHO Multinational Sstudy of Vascular Diseases in Diabetes. Diabetología. 2001;44 Suppl 2:S14-21.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 SCitaep 23;351(13):1296-305. Erratum in: N Engl J Med. 2008;18(4):4.
Perazella MA, Khan S. Increased mortality in chronic disease: a call to action: Am J Med Sci. 2006;331(3):150-3.
Hurtado de Mendoza Amat J. Autopsia como garantia de calidad en la medicina. En: Autopsia. Garantía de calidad en la medicina. Capítulo 10. La Habana, Ecimed, 2009.
OPS/OMS. Clasificación estadística internacional de enfermedades y problemas relacionados con la salud. 9na. Edición. Washington: OPS/OMS. 1997.
Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005;28(9):2280-8.
Young BA, Maynard C, Boyko EJ. Racial differences in diabetes nephropathy, cardiovascular disease and mortality in a natural population of veterans. Diabetes Care. 2003;26:2392-99.
Mehrotra R, Kermah D, Fried L, Adler S, Norris K. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008 ;19(7):1403-10.
Álvarez Gregori JA, Musso C, Macías Nuñez JF. Riñón y envejecimiento. FMC Nefrología e Hipertensión. 2006;2:16-30.
Heras M, García-Cosmes P, Fernández-Reyes MJ. Evaluación natural de la función renal en el anciano: análisis de factores de mal pronóstico asociados a la enfermedad renal crónica. Nefrología. 2013;33(4):462-9.
Heras M, Fernández MJ, Sánchez R, Guerrero MT, Molina A, Rodríguez A, et al. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up. Nefrología. 2012;32(3):300-5.
Otero J, Martínez JC, Betancourt L, Rodríguez E, García M. Aplicabilidad clínica de dos índices pronósticos de mortalidad precoz en pacientes añosos incidentes en hemodiálisis. Nefrología. 2012;32(2):213-20.
Reichert J. Consultas e ingresos hospitalarios de una población de un centro de diálisis. Nefrología. 2007;27(1):53-61.
Ritchie J, Kalva PA. Atherosclerotic renovascular disease: epidemiology and clinical manifestations. JAMA. 2014;3:21.
Knoop T, Vikse BE, Svarstad E, Leb S. Mortality in patients with IgA nephropathy. Am J Nephrol. 2013;2(5):883-90.
Nakayama M, Sato T, Sath H, Yamaguchi Y, Obara K, Kurihara I, et al. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gounyo study. Clin Exp Nephrol. 2010;14(4):333-9.
Dyck RF, Jiang Y, Osgood ND. The long-term risk of end stage renal disease and mortality among first nations among -First Nations and Non First Nations people with youth- onset diabetes. Can J Diabetes. 2014;38(4):237-43.
Kon T, Yamaji K, Sugimoto K, Ogasawara M, Kenpe K, Ogasawara H, et al. Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosus. Mod Rheumatol. 2010;20(2):168-77.
Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10.
Paueksakon P, Fogo AB. Autopsy Renal Pathology. Surg Pathol Clin. 2014;7(3):321-55.
Yasigi F, Hashmi U, Yuan H, Navala K, Mc Cullough PA. Cardiovascular issues and renal disease. Ev B Cardiology Consult. 2014;355-74.
Singh S. Cardiovascular disease in chronic disease: epidemiology and clinical manifestations. Nephrology. 2014;3(1):20-9.
Mercado-Martínez FJ, Urias-Vázquez JE. Enfermos renales hispanoamericanos en la época de las redes sociales virtuales: análisis de contenido de sus publicaciones, 2010- 2012. Rev Panam Salud Publica. 2014;35(5/6):392-8.
Trujillo Salgado JE, Vigoa Sánchez LP, Sotolongo Molina Y, Guanche Garcell H. Alteraciones cardíacas en la insuficiencia renal crónica. Correlación clínico-patológica. Rev Cubana Cardiol Cir Cardiov. 1997;11(2):65-73.
Pérez García R, Palomares-Sancho I. Estudio epidemiológico de 7316 pacientes en hemodiálisis tratados en las clínicas Fresenius Medical Care de España, con los datos obtenidos mediante la base de datos EuClid: resultados de los años 2009-2010. Nefrología (Madr). 2012;32(6):743-53.